Cargando…

The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review

BACKGROUND: Sub optimal levels of compliance and persistence with bisphosphonates are potentially compromising the reduction of post menopausal osteoporotic (PMO) fracture risk. METHODS: A structured literature search (1990–2006) was performed to identify primary research studies evaluating the rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adachi, Jonathan, Lynch, Niall, Middelhoven, Hans, Hunjan, Manjit, Cowell, Warren
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2094708/ https://www.ncbi.nlm.nih.gov/pubmed/17897451 http://dx.doi.org/10.1186/1471-2474-8-97

Ejemplares similares

Oral bisphosphonate compliance and persistence: a matter of choice?
por: Silverman, S. L., et al.
Publicado: (2010)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

Which Bisphosphonate? It's the Compliance!: Decision Analysis
por: Lee, You Jin, et al.
Publicado: (2016)

Loss of treatment benefit due to low compliance with bisphosphonate therapy
por: Penning-van Beest, F. J. A., et al.
Publicado: (2007)

Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
por: Kishimoto, Hideaki, et al.
Publicado: (2015)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Impact of the Training on the Compliance and Persistence of Weekly Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Randomized Controlled Study
por: Tüzün, Şansın, et al.
Publicado: (2013)

Atypical femoral fractures related to bisphosphonate therapy
por: Jain, Tarun Pankaj, et al.
Publicado: (2012)

Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis
por: Fraser, Lisa-Ann, et al.
Publicado: (2011)

Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis
por: Akarırmak, Ülkü, et al.
Publicado: (2016)

Bisphosphonate use after clinical fracture and risk of new fracture
por: Bergman, J., et al.
Publicado: (2018)

Subtrochanteric Fractures in Bisphosphonate-Naive Patients: Results from the HORIZON-Recurrent Fracture Trial
por: Adachi, Jonathan D., et al.
Publicado: (2011)

Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
por: Nho, Jae-Hwi, et al.
Publicado: (2016)

Bisphosphonates and Atypical Fractures of Femur
por: Yli-Kyyny, Tero
Publicado: (2011)

Atypical femoral fractures and bisphosphonates
por: Jawad, Ali S. M.
Publicado: (2017)

Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern
por: Ko, Kyung Rae, et al.
Publicado: (2020)

Atypical femoral neck fracture after prolonged bisphosphonate therapy
por: Kim, Kwang-kyoun, et al.
Publicado: (2020)

Prevention of bisphosphonate-related mandibular fractures
por: Pedrazzoli, M., et al.
Publicado: (2016)

Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017)

Bisphosphonate-related Femoral Shaft Fracture
por: Kellar, Jesse, et al.
Publicado: (2019)

Bisphosphonate Use and Fractures in Adults with Hypophosphatasia
por: Rassie, Kate, et al.
Publicado: (2019)

OA09 Vertebral fractures on bisphosphonates
por: Walshe, William, et al.
Publicado: (2023)

Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy
por: Kostoff, Matthew D, et al.
Publicado: (2014)

Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study
por: Fraser, Lisa-Ann, et al.
Publicado: (2014)

The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK: a study of patient records from the UK Clinical Practice Research Datalink
por: Ferguson, Samara, et al.
Publicado: (2015)

Acute Nontraumatic Clavicle Fracture Associated with Long-Term Bisphosphonate Therapy
por: Vun, Shen Hwa, et al.
Publicado: (2014)

Atypical metatarsal fracture in a patient on long term bisphosphonate therapy
por: Pradhan, Pavan, et al.
Publicado: (2012)

Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases
por: Bush, Lisabeth A., et al.
Publicado: (2015)

Atypical Fracture of the Proximal Shaft of the Ulna Associated with Prolonged Bisphosphonate Therapy
por: Oh, Byung Hak, et al.
Publicado: (2018)

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy
por: Dózsai, Dávid, et al.
Publicado: (2020)

Bisphosphonate therapy associated with bilateral atypical femoral fracture and delayed union
por: Gárgyán, István, et al.
Publicado: (2022)

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
por: Burden, A. M., et al.
Publicado: (2011)

Is It a Simple Stress Fracture or Bisphosphonate-related Atypical Fracture?
por: Kang, Soo Yong, et al.
Publicado: (2012)

Atypical Complete Femoral Fractures Associated with Bisphosphonate Use or Not Associated with Bisphosphonate Use: Is There a Difference?
por: Kim, Sang-Min, et al.
Publicado: (2016)

Current concepts in the management of bisphosphonate associated atypical femoral fractures
por: Rudran, Branavan, et al.
Publicado: (2021)

Do bisphosphonates cause femoral insufficiency fractures?
por: Seraphim, Andreas, et al.
Publicado: (2012)

Bisphosphonates and direct fracture healing: Area to be explored
por: Goyal, Tarun, et al.
Publicado: (2014)

Bisphosphonate-induced Atypical Femoral Shaft Fracture
por: Baig, Muhammad Usman, et al.
Publicado: (2017)

Femoral insufficiency fracture related to bisphosphonate use
por: Choudry, Misha S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nsqqp00chivvfnrt5lb56ovhrb